PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT
PCT No. PCT/FI96/00164 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Mar. 20, 1996 PCT Pub. No. WO96/29058 PCT Pub. Date Sep. 26, 1996The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug a...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YRJOELAE, REIJA MARVOLA, MARTTI MARTTILA, ESKO LAHDENPAEAE, ESA |
description | PCT No. PCT/FI96/00164 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Mar. 20, 1996 PCT Pub. No. WO96/29058 PCT Pub. Date Sep. 26, 1996The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug and a drug release controlling agent and b) an enteric coating comprising the drug release controlling agent, wherein the drug release controlling agent consists substantially of a pH-sensitive enteric polymer. Preferably the pH-sensitive enteric polymer has a pH dissolving point of at least 6.5. The composition is preferably in the form of granules. Preferably, the composition is in the form of enteric matrix granules coated with an enteric coating. The composition releases the drug gradually in the lower gastrointestinal tract. The composition is especially suitable for the administration of 3-(3-cyanophenyl)methylene-2,4-pentanedione into the colon. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0817615B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0817615B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0817615B13</originalsourceid><addsrcrecordid>eNrjZPALcA3yD3L0UXD29w3wD_YM8fT3U3DzDwLy_UKC_H18XF0Uglx9XB2DXRU8_RRCPFwVfPzDXYMU3B2DgfKefiGuwSGefkADQoIcnUN4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CBhaG5maGpk6ExEUoA8ZMuiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT</title><source>esp@cenet</source><creator>YRJOELAE, REIJA ; MARVOLA, MARTTI ; MARTTILA, ESKO ; LAHDENPAEAE, ESA</creator><creatorcontrib>YRJOELAE, REIJA ; MARVOLA, MARTTI ; MARTTILA, ESKO ; LAHDENPAEAE, ESA</creatorcontrib><description>PCT No. PCT/FI96/00164 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Mar. 20, 1996 PCT Pub. No. WO96/29058 PCT Pub. Date Sep. 26, 1996The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug and a drug release controlling agent and b) an enteric coating comprising the drug release controlling agent, wherein the drug release controlling agent consists substantially of a pH-sensitive enteric polymer. Preferably the pH-sensitive enteric polymer has a pH dissolving point of at least 6.5. The composition is preferably in the form of granules. Preferably, the composition is in the form of enteric matrix granules coated with an enteric coating. The composition releases the drug gradually in the lower gastrointestinal tract. The composition is especially suitable for the administration of 3-(3-cyanophenyl)methylene-2,4-pentanedione into the colon.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020807&DB=EPODOC&CC=EP&NR=0817615B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020807&DB=EPODOC&CC=EP&NR=0817615B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YRJOELAE, REIJA</creatorcontrib><creatorcontrib>MARVOLA, MARTTI</creatorcontrib><creatorcontrib>MARTTILA, ESKO</creatorcontrib><creatorcontrib>LAHDENPAEAE, ESA</creatorcontrib><title>PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT</title><description>PCT No. PCT/FI96/00164 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Mar. 20, 1996 PCT Pub. No. WO96/29058 PCT Pub. Date Sep. 26, 1996The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug and a drug release controlling agent and b) an enteric coating comprising the drug release controlling agent, wherein the drug release controlling agent consists substantially of a pH-sensitive enteric polymer. Preferably the pH-sensitive enteric polymer has a pH dissolving point of at least 6.5. The composition is preferably in the form of granules. Preferably, the composition is in the form of enteric matrix granules coated with an enteric coating. The composition releases the drug gradually in the lower gastrointestinal tract. The composition is especially suitable for the administration of 3-(3-cyanophenyl)methylene-2,4-pentanedione into the colon.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPALcA3yD3L0UXD29w3wD_YM8fT3U3DzDwLy_UKC_H18XF0Uglx9XB2DXRU8_RRCPFwVfPzDXYMU3B2DgfKefiGuwSGefkADQoIcnUN4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CBhaG5maGpk6ExEUoA8ZMuiA</recordid><startdate>20020807</startdate><enddate>20020807</enddate><creator>YRJOELAE, REIJA</creator><creator>MARVOLA, MARTTI</creator><creator>MARTTILA, ESKO</creator><creator>LAHDENPAEAE, ESA</creator><scope>EVB</scope></search><sort><creationdate>20020807</creationdate><title>PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT</title><author>YRJOELAE, REIJA ; MARVOLA, MARTTI ; MARTTILA, ESKO ; LAHDENPAEAE, ESA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0817615B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>YRJOELAE, REIJA</creatorcontrib><creatorcontrib>MARVOLA, MARTTI</creatorcontrib><creatorcontrib>MARTTILA, ESKO</creatorcontrib><creatorcontrib>LAHDENPAEAE, ESA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YRJOELAE, REIJA</au><au>MARVOLA, MARTTI</au><au>MARTTILA, ESKO</au><au>LAHDENPAEAE, ESA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT</title><date>2002-08-07</date><risdate>2002</risdate><abstract>PCT No. PCT/FI96/00164 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Mar. 20, 1996 PCT Pub. No. WO96/29058 PCT Pub. Date Sep. 26, 1996The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug and a drug release controlling agent and b) an enteric coating comprising the drug release controlling agent, wherein the drug release controlling agent consists substantially of a pH-sensitive enteric polymer. Preferably the pH-sensitive enteric polymer has a pH dissolving point of at least 6.5. The composition is preferably in the form of granules. Preferably, the composition is in the form of enteric matrix granules coated with an enteric coating. The composition releases the drug gradually in the lower gastrointestinal tract. The composition is especially suitable for the administration of 3-(3-cyanophenyl)methylene-2,4-pentanedione into the colon.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP0817615B1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | PERORAL COMPOSITION FOR CONTROLLED RELEASE IN THE LOWER GASTROINTESTINAL TRACT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T13%3A33%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YRJOELAE,%20REIJA&rft.date=2002-08-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0817615B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |